1 6 5 5 a r t I C l e S Synapses are continuously modified by use and experience. This synaptic plasticity is believed to be a basis of information storage in the brain. Hebbian plasticity, such as long-term potentiation (LTP) and long-term depression, is relatively rapid and synapse-specific, and is regulated by positive-feedback mechanisms. LTP and long-term depression are mediated mainly by the trafficking of AMPA receptors (AMPARs) into and out of stimulated synapses 1 . In contrast, homeostatic plasticity involves the global modification of synapses and operates over longer timescales. Homeostatic plasticity provides a global negative feedback and is crucial for stabilizing neuronal network function 2 . Synaptic scaling is one form of homeostatic plasticity that occurs at excitatory neurons, and it results in the adjustment of the strength of all excitatory synapses up or down via modification of AMPAR amounts 2 . Several molecules, including BDNF, CaMKII, Arc, Plk2, TNF-α, all-trans retinoic acid and mGluR-Homer1a, have been identified to be involved in synaptic scaling (reviewed in refs. 2,3). However, the detailed signaling pathways and molecular and biochemical changes at synapses associated with homeostatic synaptic scaling still need to be established 2,3 .
a r t I C l e S specificity in vitro 15 . However, accumulating evidence indicates that CaMKII isoforms also have isoform-specific functions. CaMKIIα is critical for hippocampal LTP 14 and serves as a scaffold for recruitment of proteasomes to dendritic spines 16 . In contrast, CaMKIIβ is important for neurite extension 17 , for maintenance of dendritic spine structure 18 , for dendritic patterning through centrosome regulation 19 and for proper synaptic targeting of CaMKIIα 20 . They are also differently regulated by excitatory activity [21] [22] [23] [24] : chronic elevated excitatory activity increased the CaMKIIα/CaMKIIβ ratio, whereas inactivity decreased the CaMKIIα/CaMKIIβ ratio. Furthermore, the general CaMKII inhibitor KN-93 or knockdown of CaMKIIβ prevented the changes in AMPAR miniature excitatory postsynaptic current (mEPSC) by activity blockade 22, 23 . These results suggest that CaMKII is involved in the expression of synaptic scaling. However, the regulatory targets of CaMKIIα and CaMKIIβ isoforms mediating homeostatic plasticity remain unclear.
Here we report that the bidirectional regulation of GKAP amounts at synapses is controlled by differential phosphorylation of GKAP by different CaMKII isoforms, which are activated by Ca 2+ entry through different channels. Furthermore, the turnover of GKAP at synapses is required for the normal activity-dependent remodeling of PSD protein composition as well as homeostatic synaptic scaling.
RESULTS
CaMKII controls activity-dependent GKAP turnover at synapses Chronic activity modulation of cultured hippocampal neurons induces bidirectional and reversible changes in the protein composition of PSD 4 . GKAP was one of major scaffolding proteins that showed an activity-dependent turnover at PSDs 4 . Because CaMKII is regulated by activity and has a role in the activity-dependent recruitment of proteasomes 16 , we tested whether CaMKII is involved in the regulation of GKAP. Blocking CaMKII activity with KN-93, but not with inactive analog KN-92, abolished not only the tetrodotoxin (TTX)-dependent accumulation of GKAP and PSD-95 but also the bicuculline (Bic)-induced depletion of GKAP and PSD-95 at synaptic sites ( Fig. 1) . or KN-92 alone had no substantial effects on the synaptic levels of GKAP and PSD-95 ( Fig. 1c-e ). Thus, CaMKII activity controls both activity-dependent accumulation and removal of GKAP and PSD-95 at synapses.
How does CaMKII activity regulate both recruitment and accumulation as well as removal of GKAP at synapses, which are seemingly opposed processes? As CaMKII requires Ca 2+ for activation, we addressed whether the sources of the Ca 2+ influx are different, by blocking two major neuronal Ca 2+ channels, NMDA receptors and L-type voltage-dependent Ca 2+ channels (L-VDCCs). The NMDA receptor antagonist AP5 completely abolished Bic-induced GKAP and PSD-95 removal but had no effect on TTX-dependent accumulation of GKAP and PSD-95 at synapses ( Fig. 1f,g) . In contrast, the L-VDCC antagonist nimodipine (Nimo) prevented the TTXinduced accumulation of GKAP and PSD-95 but had no effect on Bic-induced depletion of GKAP and PSD-95. Nimo alone did not affect the basal number of GKAP and PSD-95 puncta substantially. Thus, CaMKII activation through the NMDA receptor promotes removal of GKAP and PSD-95 from synapses, whereas CaMKII activation mediated by L-VDCC increases the abundance of these proteins at synapses. npg a r t I C l e S CaMKII isoform-specific regulation of GKAP turnover To study the molecular basis of CaMKII-dependent bidirectional control of GKAP, we analyzed the roles of CaMKIIα versus CaMKIIβ, which are highly expressed in neurons. We specifically suppressed expression of CaMKIIα or CaMKIIβ by RNA interference (RNAi), using plasmid-based constructs expressing small hairpin RNAs (shRNAs), whose specificity and efficacy have been demonstrated ( Supplementary Fig. 1a ) 16, 18 .
RNAi-mediated knockdown of CaMKIIα (CaMKIIα RNAi) did not affect amounts of synaptic GKAP substantially under normal growth conditions (control; Fig. 2a,b and Supplementary Fig. 1b,d ) but completely blocked Bic-induced decrease in the amount of synaptic GKAP (Fig. 2a,b and Supplementary Fig. 1c,d) . In contrast, CaMKIIα RNAi had no effect on the increase in GKAP amount upon treatment with TTX. Overexpression of CaMKIIβ in cells subjected to CaMKIIα RNAi did not restore the Bic-induced loss of synaptic GKAP ( Supplementary Fig. 1b-d) . These results indicate that CaMKIIα is specifically required for the Bic-stimulated removal of GKAP from synapses. Unlike CaMKIIα RNAi, RNAi-mediated knockdown of CaMKIIβ (CaMKIIβ RNAi) significantly reduced the number of GKAP clusters (P < 0.001) to less than 40% of the amount for the control grown in untreated normal growth conditions ( Fig. 2a,b) . This could reflect the requirement of CaMKIIβ for GKAP accumulation in synapses or might be secondary to the loss of dendritic spines, as CaMKIIβ is implicated in synapse formation and the maintenance of dendritic spines 17, 18 . Nonetheless, neurons subjected to CaMKIIβ RNAi still exhibited further reduction in the number of GKAP clusters (P < 0.001) after Bic treatment. However, CaMKIIβ RNAi completely blocked the increase in the amount of GKAP clusters stimulated by addition of TTX ( Fig. 2a,b) . Thus, CaMKIIβ is required for the increase of synaptic GKAP by TTX. To corroborate the finding, we subjected cells to CaMKIIβ RNAi and also expressed the actin-association domain of CaMKIIβ (residues 285-542) which partly rescued the CaMKIIβ RNAi-mediated loss of dendritic spines 18 . However, these neurons still did not exhibit a TTX-induced increase in the amount of GKAP clusters (Fig. 2b) . To test the role of actin association in the differential function of CaMKII isoforms, we generated a chimeric CaMKIIα with the actin association domain grafted from CaMKIIβ (designated CaMKIIα-AD; Fig. 2c ). When we transfected a vector encoding CaMKIIα-AD into neurons subjected to CaMKIIβ RNAi, the TTX-dependent increase in GKAP at synapses was restored ( Fig. 2c,d and Supplementary Fig. 1e ). In contrast, expression of wild-type CaMKIIα in neurons subjected to CaMKIIβ RNAi did not rescue the defects caused by knockdown of CaMKIIβ ( Fig. 2d) . Expression of RNAi-resistant versions of genes encoding respective CaMKII isoforms in cells subjected to RNAi restored the normal activity-dependent turnover of endogenous GKAP ( Supplementary  Fig. 1a,f) . Thus, these data indicate that the synaptic accumulation of GKAP during inactivity requires CaMKIIβ activity, and the actinassociation activity of CaMKIIβ is important for the process. npg a r t I C l e S We next examined the effect of Bic and TTX on the activation of the two CaMKII isoforms in hippocampal neurons. Bic increased the activation of both CaMKIIα and CaMKIIβ by more than sixfold compared to untreated control condition ( Fig. 2e) , which we determined by phospho-CaMKII antibody that recognizes autophosphorylation of both isoforms (CaMKIIα phospho-(p)Thr286 and CaMKIIβ pThr287). In contrast, suppressing activity of hippocampal neurons by TTX increased the autophosphorylation of CaMKIIβ by more than threefold after 12 h without substantial changes in phosphorylated CaMKIIα amounts ( Fig. 2e,f) . After a 24-h TTX treatment, CaMKIIβ again exhibited more than threefold greater autophosphorylation than CaMKIIα did. Neither Bic nor TTX substantially changed the total amount of either CaMKII isoform. These results indicate that CaMKIIβ is a dominantly active form of CaMKII isoforms during chronic inactivity.
CaMKII activity promotes GKAP degradation by the UPS
We found that increasing activity removed GKAP from synapses ( Fig. 1b,d,e ), which is likely due to degradation of GKAP by the UPS 4 .
Bic treatment (24 h) substantially decreased total GKAP amount to ~20% of that in the control (Fig. 3a) . Incubation with proteasome inhibitors, MG132 or lactacystin (Lactacys) increased total GKAP amount (>180%), similarly to TTX treatment. Total GKAP amount increased to ~150% of baseline after 24 h TTX treatment as well as after AP5 or 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) treatments. In contrast, total GluR2 and GluR3 protein amounts were not substantially affected by any of these treatments ( Fig. 3a) . Incubation with KN-93, but not KN-92, prevented the Bic-induced decrease in GKAP amounts (Fig. 3b,c) , indicating the involvement of CaMKII in GKAP degradation.
Although these data suggest that GKAP undergoes UPS-dependent degradation, it is unclear whether GKAP is directly ubiquitinated in a CaMKII-regulated manner. To address this, we performed in vitro ubiquitination assays. When we incubated purified recombinant glutathione-S transferase fused to full-length GKAP (GST-GKAP) with ubiquitin and P2 fraction (synaptosomeenriched fraction) of rat forebrain as a source of E2 and E3 enzymes ( Fig. 3d) , electrophoresis revealed the appearance multiple npg a r t I C l e S GST-GKAP protein bands of higher molecular weights and a decrease in the amount of GST-GKAP. We did not observe the shift to higher molecular weight in the absence of Ca 2+ ion and without the addition of the P2 fraction. The molecular-weight shifts were inhibited by the substitution of normal ubiquitin with a triple lysine mutant of ubiquitin (3KR-Ub), which cannot catalyze polyubiquitin chain elongation. This result indicates that the higher-molecularweight GKAP bands represent bona fide polyubiquitinated GKAP. Finally, blocking CaMKII activity in the P2 fraction by KN-93 completely abolished polyubiquitination of GKAP. GST alone did not show such mobility shifts in any of these conditions (data not shown). Collectively, these results indicate that GKAP undergoes polyubiquitination by brain synaptosome extracts in a manner dependent on the presence of Ca 2+ and CaMKII activity. We also examined by immunostaining the effect of proteasome inhibitors, MG132 and lactacystin, on Bic-induced removal of GKAP from synapses. These proteasome inhibitors did not block the Bicinduced depletion of synaptic GKAP; GKAP cluster density was similarly reduced by Bic in the presence or absence of these proteasome inhibitors (Fig. 3e,f) . Rather, GKAP formed large aggregates in the soma and proximal dendrites after treatment of neurons with Bic plus MG132 or Bic plus Lactacys (Fig. 3e) , which is often observed for ubiquitinated proteins after the inhibition of proteasome activity 25 . In contrast, PSD-95 did not show such large aggregation after treatment with Bic and proteasome inhibitors. None of these treatments substantially affected the cluster density of PSD-93 (also known as Chapsyn-110). These results suggest that GKAP is degraded by proteasomes after being transported away from synapses, rather than being degraded directly at the synapse.
GKAP is a substrate of CaMKII
To determine whether GKAP phosphorylated by CaMKII directly, we first performed the in situ phosphorylation assay of PSDs 26 , in which we incubated purified PSDs with [ 32 P]ATP under conditions that either promote (by adding Ca 2+ and CaM) or suppress (by adding EGTA) endogenous CaMKII activity present in the PSD. We examined phosphorylation of GKAP, Shank or NR2B by subsequent immunoprecipitation of these proteins under denaturing conditions to minimize coprecipitation of interacting proteins. Addition of Ca 2+ and CaM stimulated phosphorylation of multiple bands in the PSD fraction (Fig. 4a) . The stimulation of endogenous CaMKII activity strongly increased incorporation of 32 P into GKAP and Shank, as well as into the known CaMKII substrate NR2B 26 . These data show that GKAP can be phosphorylated by CaMKII in the PSD.
To determine whether CaMKII phosphorylates GKAP directly, we performed in vitro phosphorylation of purified GST-fusion proteins of various domains of GKAP using purified rat brain CaMKII ( Fig. 4b ; for domain structure of GKAP, see Fig. 4c ). The repeat regions of GKAP that bound to PSD-95 (R1-R2, R1-R3 and R3-R5), as well as the DLC-binding domain of GKAP (DLC-BD), were directly phosphorylated by CaMKII in a Ca 2+ and CaM-dependent manner. The guanylate kinase domain of PSD-95 that binds to GKAP was not CaMKII phosphorylation attenuates GKAP binding to PSD-95 Because the N-terminal repeat region of GKAP mediates direct interaction with PSD-95 (ref. 5), we hypothesized that CaMKII phosphorylation of this region (Fig. 4b) would disrupt the GKAP−PSD-95 interaction. GKAP and PSD-95 formed co-clusters when overexpressed together in monkey fibroblast-like cell line, COS-7 (ref. 5) (cluster formation was observed in 95% cells examined; Fig. 4d ). When expressed alone, GKAP and PSD-95 exhibited diffuse staining without any cluster formation (data not shown). Formation of GKAP−PSD-95 clusters was almost completely prevented by expression of a constitutively active form of CaMKIIα (T286D mutant; cluster formation was observed in only 8% cells); in these cells, distribution of GKAP and PSD-95 was largely diffuse (Fig. 4d) . Expression of wild-type CaMKIIα also inhibited coclustering, though to a lesser extent than that observed with expression of the CaMKIIα T286D mutant (cluster formation was observed in 60% of cells; Fig. 4d ). In contrast, coexpression of kinase-dead mutant of CaMKIIα (K42R) had no effect on coclustering (cluster formation in was observed in 95% of cells; Fig. 4d ), indicating that protein kinase activity of CaMKII is required for the disruption of the GKAP-PSD-95 complex. Thus, CaMKIIα activity can regulate the association of GKAP and PSD-95 in cells.
GKAP1 (also known as SAPAP1) contains multiple sequences that conform to the CaMKII phosphorylation consensus of (K/R)xx (S/T)Φ (where S/T is the phosphorylation site, and Φ represents a hydrophobic amino acid) 27 . Among them, serine residues (Ser54 and Ser201) in R1 and R5 (conserved in all GKAP isoforms; for amino acid sequences, see Fig. 4c ) have been shown to be phosphorylated in vivo by mass spectrometry studies of the PSD 28 . We tested whether phosphorylation of Ser54 and Ser201 affects GKAP interaction with PSD-95, by changing these residues to either alanine or aspartic acid individually or in combination. We measured binding to PSD-95 in the yeast two-hybrid system, using GKAP as 'bait' . Single mutations of Ser54, Ser83 (in R2), Ser114 (in R3), Ser148 (in R4) or Ser201 to alanine or aspartic acid did not affect GKAP interaction with the guanylate kinase domain of PSD-95 ( Supplementary Fig. 2a,b) . However, when we mutated both Ser54 and Ser201 to alanine (S54A,S201A) or aspartic acid (S54D,S201D), GKAP interaction with PSD-95 guanylate kinase domain was greatly diminished (Supplementary Fig. 2b) . Double mutations of Ser54 and Ser83 had no effect on PSD-95 interaction, confirming the specificity (Supplementary Fig. 2b) . In contrast, none of these mutations affected GKAP interaction with DLC2. Furthermore, the S54D,S201D double mutant did not cluster with PSD-95 in COS cells (cluster formation was observed in < 1% of cells; Fig. 4d) . These results suggest that Ser54 and Ser201 have a critical role in GKAP interaction with PSD-95 and phosphorylation of these residues impairs PSD-95 binding.
This conclusion was supported by coimmunoprecipitation experiments (Fig. 4e) . The amount of GKAP S54A,S201A and S54D,S201D mutants precipitating with Myc-PSD-95 was greatly reduced compared to that for wild-type GKAP (Fig. 4e) . In contrast, the amount 
Phosphorylation of Ser54 is critical for GKAP ubiquitination
To determine CaMKII phosphorylation site(s) in GKAP that are critical for induction of polyubiquitination, we tested various GKAP mutants for in vitro ubiquitination. The GKAP S54A mutant was not polyubiquitinated regardless of the presence of Ca 2+ (Fig. 5a) .
Deletion of the entire R1 that contains Ser54 (mutant designated ∆R1) also did not exhibit polyubiquitination. In contrast, the phosphomimic GKAP S54D mutant showed strong polyubiquitination, even in the absence of Ca 2+ (Fig. 5a) . The polyubiquitination of the GKAP S54D mutant was effectively blocked by 3KR-Ub but was not affected by the presence of CaMKII inhibitors, KN-93 or autocamtide-2 related inhibitory peptide (Fig. 5b) . Therefore, polyubiquitination of the GKAP S54D mutant does not require Ca 2+ and CaMKII activity, indicating that phosphorylation of Ser54 is necessary and sufficient to induce polyubiquitination of GKAP. Phosphomimic or phosphorylation-defective mutations in the DLC-BD (S340D,S384D and S340A,S384A double mutants) exhibited normal Ca 2+dependent polyubiquitination (Fig. 5c) , confirming the specificity of S54D mutation for the polyubiquitination of GKAP.
To confirm that the phosphorylation of Ser54 is involved in the Bic-dependent polyubiquitination of GKAP in neurons, we immunoprecipitated GKAP under the denaturing conditions and probed for the presence of phosphorylated Ser54 (pSer54) using an antibody that showed >100-fold specificity to the pSer54-containing peptide over the nonphosphorylated peptide (Supplementary Fig. 3a) .
Staining with the anti-pSer54 antibody exhibited multiple immunoreactive GKAP bands of higher molecular weights (resembling the pattern of polyubiquinated GKAP) only in samples immunoprecipitated from Bic-treated neurons (Bic alone and Bic plus MG132), and not from samples treated with TTX, TTX plus MG132 or MG132 alone (Supplementary Fig. 3b ). These results demonstrate that chronic Bic treatment promotes specific phosphorylation of Ser54 and the polyubiquitination of GKAP in hippocampal neurons. In addition, these results predicted that the S54A mutant would show a defect in Bic-induced decrease in GKAP amounts. Indeed, when expressed in neurons, GKAP S54A did not to show Bic-dependent reduction (Fig. 5d-f) . In contrast, GKAP S54A clearly led to TTXinduced accumulation at synapses (P < 0.001). In contrast, exogenous wild-type GKAP clearly showed normal activity-dependent turnover similar to that of endogenous GKAP. Collectively, these results highlight the importance of Ser54 phosphorylation in polyubiquitination and activity-dependent degradation of GKAP.
Myosin Va transports GKAP to synapses
To unravel the molecular mechanisms behind the stabilization and recruitment of GKAP during inactivity, we examined the importance of GKAP association with an actin-based motor protein myosin Va (MVa), which has been proposed as a potential mechanism for the transport of GKAP to synapses 9 . To test this possibility, we first addressed the importance of GKAP interaction with the DLC, which provides a bridge to MVa. DLC forms a dimer and binds to various targets via two conserved amino sequences, (K/R)xTQT or GIQVD ( Supplementary  Fig. 4a) 29 . Peptides based on the two sequences bind the same binding pocket in the DLC and prevent DLC interactions 29 . To prevent DLC npg a r t I C l e S interaction with GKAP, we used a synthetic peptide that has a DLCbinding consensus KETQT sequence fused to the antennapedia peptide sequence, which facilitates neuronal uptake of the peptide (designated Antp-KETQT) 30 . Incubation of neurons with Antp-KETQT peptide for 18 h greatly reduced GKAP puncta density to less than 25% of control amount (Supplementary Fig. 4b,d) . In contrast, the numbers of NR1 and synaptophysin puncta were not substantially affected by Antp-KETQT, indicating that synapse numbers were not changed. Control Antp-Kv1.4 peptide (Antp fused to the C-terminal sequence of Kv1.4) 30 did not affect the cluster numbers of all examined proteins. Both Antp peptides did not change total protein levels of GKAP, PSD-95 and GluR2 (Supplementary Fig. 4e) , indicating that the reduction in GKAP cluster numbers was not due to the reduction of total GKAP amount. To corroborate the data, we used a mutant GKAP that has a deletion in DLC-BD (designated ∆DLC-BD). The ∆DLC-BD mutant was largely confined to the dendritic shaft, indicating that synaptic targeting of ∆DLC-BD mutant was severely impaired ( Supplementary  Fig. 4f ). Taken together, these results suggest that DLC interaction is required for the proper targeting of GKAP to synapses. We next tested the role of MVa in GKAP transport to synapse by using RNAi-mediated knockdown of MVa (MVa RNAi). In COS cells, MVa RNAi specifically reduced MVa amounts but did not affect PSD-95 or GKAP (Supplementary Fig. 5a ). When introduced into neurons, MVa RNAi reduced MVa staining intensities to >50% in soma and >85% in dendrites compared to nontransfected neighboring neurons (Supplementary Fig. 5b,c) , showing effective knockdown of endogenous MVa. In neurons, MVa RNAi significantly (P < 0.001) reduced the number of GKAP clusters (Fig. 6a,b ) and increased GKAP staining in the soma (Supplementary Fig. 5d,e ). MVa knockdown completely abolished the TTX-induced increase of GKAP amounts at synapses, while it exhibited no effect on Bic-dependent reduction of synaptic GKAP clusters (Fig. 6c,d) . These results strongly suggest that GKAP is actively recruited to synapses via MVa motor proteins.
As the MVa-DLC interaction is important for GKAP transport to synapses, we next examined the role of CaMKII in this process. The DLC-BD of GKAP contained two potential CaMKII phosphorylation sites (Ser340 and Ser384; Fig. 4c) , which may regulate GKAP-DLC interaction. We tested this possibility by coimmunoprecipitation experiments after expressing the phosphomimic (S340D,S384D) and phosphorylation-defective (S340A,S384A) GKAP double mutants with DLC in COS cells. Both wild-type GKAP and GKAP S340A,S384A mutant immunoprecipitated with DLC (Fig. 6e) . In contrast, GKAP S340D,S384D and GKAP ∆DLC-BD mutants did not immunoprecipitate with DLC, suggesting that CaMKII phosphorylation of Ser340 and Ser384 prevents the interaction of GKAP with DLC. Thus, in terms of DLC interaction, GKAP S340A,S384A and GKAP S340D,S384D are dissociation and association mutants, respectively. When GKAP S340A,S384A and GKAP S340D,S384D mutants were expressed in neurons, they showed severely impaired synaptic targeting, as evidenced by a large reduction in their npg a r t I C l e S synaptic cluster numbers under the control condition ( Fig. 6f,g ; P < 0.001). The GKAP S340D,S384D mutant showed the greatest impairment (P < 0.001 compared to S340A,S384A). Neither mutant showed the TTX-driven increase in synaptic cluster numbers ( Fig. 6f,g ; P > 0.23). These data indicate that both DLC interaction and CaMKII phosphorylation of DLC binding region are required for the proper GKAP targeting to synapses and accumulation of GKAP during inactivity.
GKAP turnover is required for homeostatic synaptic scaling To examine the importance of GKAP turnover in other synaptic protein turnover and homeostatic synaptic scaling, we used a GKAP turnover mutant that is defective in the bidirectional changes (∆R1). When transfected into neurons, GKAP ∆R1 showed synaptic targeting similar to that of the transfected wild-type GKAP (Fig. 7a,b and Supplementary Fig. 6a ). Also, total expression of ∆R1 was very similar to that of wild-type GKAP (data not shown). However, neither Bic nor TTX treatment substantially changed the amount of ∆R1 at synapses ( Fig. 7a,b) . Therefore, GKAP ∆R1 is defective in bidirectional activity-dependent turnover at synapses. To address the importance of GKAP turnover in activity-dependent remodeling of PSD proteins, we overexpressed GKAP ∆R1 in hippocampal neurons and examined its effect on two key scaffold proteins in the PSD, PSD-95 and Shank. We used wild-type GKAP as control because it showed normal activity-dependent turnover (Fig. 7a,b) . Neurons overexpressing wild-type GKAP showed Bic-and TTXdependent changes in amounts of PSD-95 and Shank at synapses, which were indistinguishable from the amounts in neighboring nontransfected neurons (Fig. 7a,c,d and Supplementary Fig. 6b) . In contrast, both Bic-and TTX-driven changes in synaptic PSD-95 and Shank were abolished in neurons expressing the GKAP ∆R1 mutant (Fig. 7a,c,d) . In addition, the GKAP ∆R1 mutant also blocked phosphorylation of Ser295 of PSD-95 ( Fig. 7e,f) , which has been shown to be important for the synaptic accumulation of PSD-95 during inactivity 31 . Corroborating this conclusion, overexpression of the degradation mutant, S54A, specifically blocked the Bic-induced reduction in synaptic PSD-95 amounts, whereas it did not affect TTXinduced increase in PSD-95 ( Supplementary Fig. 6c,d) . Furthermore, GKAP targeting mutants, S340A,S384A and S340D,S384D, impaired normal activity-dependent turnover of PSD-95 in both directions (Supplementary Fig. 6e,f) . Therefore, these results indicate that GKAP turnover is critical for the activity-dependent turnover of PSD-95 and Shank at synapses.
We then examined activity-dependent changes of surface AMPARs. Chronic activity modulation led to bidirectional changes in surface expression of AMPARs, which are associated with synaptic scaling. Neurons overexpressing wild-type GKAP exhibited similar activitydependent changes (Fig. 7g,h) . In contrast, overexpression of the GKAP ∆R1 mutant eliminated the activity-dependent changes in the surface expression of both GluA1 and GluA2 in both Bic-and TTXtreated neurons (Fig. 7g,h) .
To examine the importance of GKAP turnover in synaptic scaling we directly measured mEPSCs in cultured hippocampal neurons (Fig. 8) . The amplitude of basal mEPSCs was unaffected by overexpression of either wild-type GKAP or GKAP ∆R1, compared to untransfected neurons in the same culture (Fig. 8a,b) . Treatment with TTX caused an increase in mEPSC amplitude in wild-type GKAP-expressing cells as well as in untransfected cells ( Fig. 8b ; P < 0.01). Conversely, Bic treatment reduced mEPSC amplitude in both wild-type GKAP-expressing and nontransfected neurons (Fig. 8a,b ; P < 0.01). Also, the cumulative frequency plots of mEPSC amplitudes from wild-type GKAP-transfected neurons showed a leftward shift with Bic treatment and rightward shift with TTX treatment (Fig. 8c) , consistent with synaptic scaling (P < 0.001, Kolmogorov-Smirnov test). In sharp contrast, neurons expressing GKAP ∆R1 did not show either TTX-or Bic-induced changes in the average mEPSC amplitude (Fig. 8b) or shifts in mEPSC amplitude distribution (Fig. 8c) . Thus overexpression of GKAP ∆R1 blocked synaptic scaling in response to both hyperactivity and hypoactivity, just as it blocked the normal turnover of PSD-95 and Shank in synapses and prevented changes in npg a r t I C l e S surface AMPARs. We did not observe substantial changes in the frequency of mEPSCs under any of these conditions (Fig. 8d) . Consistent with these data, the GKAP S54A mutant also blocked the Bic-dependent downscaling of mEPSCs, and GKAP S340A,S384A and GKAP S340D,S384D mutants did not support TTX-induced upscaling of mEPSCs ( Supplementary Fig. 6g,h) .
To confirm the importance of GKAP in synaptic scaling, we designed shRNA sequences targeting the mRNA encoding GKAP. The specificity and efficacy of these shRNAs are shown in Supplementary  Figure 7 . RNAi-mediated knockdown of GKAP (GKAP RNAi; by shRNA #3-1) did not influence the amplitude of basal mEPSCs substantially. However, GKAP RNAi completely abolished the bidirectional synaptic scaling, whereas untransfected neighboring neurons clearly showed activity-dependent synaptic scaling (Fig. 8e) . Notably, GKAP RNAi greatly reduced the mEPSC frequency ( Fig. 8f) , suggesting that GKAP RNAi reduced the number of synapses. GKAP RNAi also abolished activity-dependent turnover of PSD-95 and Shank (Supplementary Fig. 7e-g) . The immunostaining and electrophysiological data indicate that activity-dependent turnover of GKAP is critical for regulation of synaptic protein composition and homeostatic synaptic scaling.
Finally, we addressed the relative importance of GKAP turnover in synaptic scaling with respect to that of other known players in synaptic scaling. For this, we examined two proteins, Arc and Plk2 (also known as SNK), whose expression is induced by overexcitation [32] [33] [34] [35] [36] . Overexpression of ∆R1 affected picrotoxin (PTX)-induced expression of neither Arc nor Plk2 (Supplementary Fig. 8a-d) , indicating that ∆R1 did not impair the signaling pathway(s) leading to the induction of these proteins. Considering that ∆R1 overexpression effectively blocked synaptic scaling (Fig. 8) , these results suggested that GKAP turnover is necessary for Arc and Plk2 to exert their effect on synaptic scaling. To corroborate this notion, we examined the effect of ∆R1 on the Plk2-mediated removal or degradation of PSD-95 from synapses 36 . Overexpression of Plk2 removed PSD-95 from synapse in the proximal dendrites of transfected neurons ( Supplementary  Fig. 8e-g) . Overexpression of wild-type GKAP and Plk2 did not influence PSD-95 removal substantially. In contrast, overexpression of ∆R1 with Plk2 abolished Plk2-mediated removal of PSD-95, and the S54A mutant exhibited the same effect (Supplementary Fig. 8e-g) . These results suggest that GKAP removal at synapses is prerequisite for Arc and Plk2 action and additionally support the importance of activitydependent GKAP turnover in synaptic scaling.
DISCUSSION
Activity modifies the protein composition of the PSD. Synaptic scaffolding proteins are particularly well-suited for the 'driver' role in PSD remodeling as their change can influence the levels of multiple interacting proteins. GKAP is a central member of the axis of major scaffolds in the PSD, consisting of PSD-95-GKAP-Shank 10,37 . However, compared to PSD-95 and Shank, which have various roles in synaptic function including glutamate receptor trafficking, synapse formation and spine morphogenesis 37, 38 , little is known about the cell biology and function of GKAP. Here we defined a critical role for GKAP in activity-dependent turnover of PSD-95 and Shank in the PSDs and in homeostatic synaptic scaling.
UPS-dependent protein degradation has emerged as an important theme underlying synaptic plasticity 4, 16, 39, 40 . A distinguished characteristic of activity-dependent turnover of PSD proteins is that groups of synaptic proteins are co-regulated, perhaps via control of master organizing proteins in the PSD 4 . Several characteristics of GKAP fit well for an organizer role within the PSD. First, GKAP is an indispensable central linker for the assembly of PSD-95-GKAP-Shank complexes at synapses 8 , and PSD-95, GKAP and Shank are mutually dependent on each other for stable accumulation at synapses 12, 41 . Indeed, activity-dependent turnover of PSD-95 and Shank was dependent on the turnover of GKAP. Second, GKAP is one of the direct substrates of the UPS (Fig. 4 and ref. 4) . Third, and most importantly, the synaptic accumulation of GKAP is controlled bidirectionally by synaptic activity. The level of activity is decoded by different Ca 2+ channels. Ca 2+ influx through the NMDA receptor triggers polyubiquitination and degradation of GKAP. In contrast, Ca 2+ influx through L-VDCC is required for the synaptic accumulation of GKAP during inactivity. However, it is unlikely that GKAP turnover controls all PSD protein remodeling processes. A group of PSD proteins showed opposite changes to GKAP in response to altered activity, for example, NR2A and CaMKIIα 4 . After GKAP turnover, synaptic scaling requires additional players such as Plk2 to target other synaptic protein complexes for activity-dependent degradation by the UPS 33, 36 .
The opposing functions of CaMKIIα and CaMKIIβ in the bidirectional synaptic scaling are well documented [22] [23] [24] , but the specific regulatory targets of these enzymes have remained unclear. Our finding indicates that GKAP is the critical substrate of these CaMKII isoforms for the activity-dependent control of synaptic strength. How does the activation of CaMKIIα versus CaMKIIβ exert different effects on GKAP turnover? Activity modulates synaptic levels of CaMKIIα and CaMKIIβ, rendering CaMKIIα as a dominant species during overexcitation but leaving CaMKIIβ as a major kinase during low-level activity [21] [22] [23] [24] . Therefore, we expect that Ca 2+ influx through NMDA receptors during high activity preferentially acts through CaMKIIα, which translocates to the PSD during high activity, and recruits proteasomes to dendritic spines 16 . In contrast, Ca 2+ influx through L-VDCCs during low-level activity (activated by spontaneous release of glutamate and miniature EPSPs) 42 preferentially stimulates CaMKIIβ, which has higher sensitivity to Ca 2+ and CaM 43 , is associated with actin concentrated at the base of dendritic spine heads 44 , where L-VDCCs protein are also localized 45 .
What are the underlying molecular mechanisms for GKAP depletion and accumulation at synapses? Our results suggest a removal mechanism in which CaMKIIα phosphorylation in the N-terminal repeat region of GKAP disrupts GKAP interaction with PSD-95 and promotes UPS-dependent degradation (Supplementary Fig. 9a ). Although dissociation from PSD-95 requires phosphorylation of Ser54 and Ser201, Ser54 phosphorylation was sufficient for polyubiquitination of GKAP. Notably, the S54D mutant did not show Bic-induced reduction. This is probably due to the overexpressioninduced dominant-negative effect of inhibiting polyubiquitination of the S54D mutant itself by saturating specific E3 ubiquitin ligase. GKAP is likely transported away from synapses before degradation by proteasomes, as preventing proteasome activity did not protect synaptic GKAP but rather produced large aggregates of GKAP in the soma. However, this view is different from the previous report proposing in situ degradation of GKAP at synapses 4 . In addition, that report showed a completely opposite activity-dependent regulation of . At present the basis of these discrepancies is unclear, but differences in the density of hippocampal neurons and the concentration of proteasome inhibitors applied to culture might have contributed to the discrepancies. It is also unclear from our data whether ubiquitination of GKAP occurs at or near synapses. Additional studies are necessary to address these questions.
For the accumulation mechanism for GKAP ( Supplementary  Fig. 9b ), we propose that β-CaMKII phosphorylation of Ser340 and npg a r t I C l e S Ser384 in the DLC-binding domain of GKAP promotes the dissociation of GKAP from MVa-DLC2 motor protein complexes that transport GKAP to the base of the PSDs, and then the 'unloaded' GKAP incorporates into the PSDs. For this, CaMKIIβ association with the actin cytoskeleton was critical, presumably because it provides spatially favored position to regulate the interaction. A similar regulatory role of CaMKII has been shown for MVa-mediated transport of GluR1 to synapses 46 and for Kif17-mediated transport of Mint1-NMDAR complex in spines 47 .
It is remarkable that deletion of R1 in GKAP was sufficient to block the bidirectional activity-dependent turnover of GKAP, which is different from S54A mutation that blocked only Bic-induced removal from synapses. One major difference between these two mutants is the CaMKII-dependent dissociation from PSD-95. The S54A mutant has Ser201, which allows CaMKIIα to prevent GKAP interaction with PSD-95 by phosphorylation, as suggested by the impaired PSD-95 interaction of the S54D,S201D mutant (Fig. 4e,f) . In contrast, unlike wild-type GKAP, ∆R1 mutant retained ∆R1-PSD-95 co-clusters even in the presence of constitutively active CaMKIIα in COS cells (Supplementary Fig. 10 ). Thus, it is likely that deletion of the R1 likely induces changes in the overall conformation of the GKAP repeat region, so that the additional CaMKIIα regulation site in R5 (Ser201) is masked, rendering GKAP resistant to CaMKIIα regulation of its interaction with PSD-95. These results suggest that the dissociation of GKAP from PSD-95 is required for the accumulation or recruitment of GKAP. Additional studies are required to clarify how deletion of R1 prevents GKAP accumulation by inactivity. Furthermore, the CaMKII isoform-specific phosphorylation of GKAP at different sites needs to be tested by additional biochemical experiments.
GKAP RNAi not only prevented synaptic scaling measured by changes in mEPSC amplitude ( Fig. 8e) but, unlike GKAP turnover mutant ∆R1, also had an additional effect of reducing mEPSC frequency. As mEPSC frequency is mostly determined by the number of synapses, the data suggest that GKAP RNAi led to a loss of synapses. Thus, GKAP is not only important for the activity-dependent remodeling of synapses and synaptic scaling but also an essential scaffolding protein of the PSDs for the maintenance of excitatory synapses.
Bic is a GABA A receptor antagonist commonly used to induce synaptic scaling and indirectly enhances overall excitatory activity in neurons by reducing inhibitory inputs to excitatory neurons. Synaptic scaling is thought to occur in all synapses 2 , as cumulative histograms showed a shift of entire mEPSC amplitude distribution toward smaller values after Bic treatment (Fig. 8c) . Consistent with this idea, cumulative distribution of GKAP cluster intensities revealed a similar shift after Bic treatment (Supplementary Fig. 11c) , indicating that the Bic treatment reduced the amount of GKAP from most synapses (if not all). Therefore, Bic has a global effect and, unlike synapse-specific Hebbian-type plasticity, synaptic scaling affects all synapses.
Proteasome inhibitor treatments did not induce apoptosis of neurons ( Supplementary Fig. 12) , indicating the specificity of proteasome activity for GKAP degradation. GKAP has been shown to be polyubiquitinated by TRIM3 ubiquitin ligase 48 , which raises a possibility that TRIM3 may be involved in the CaMKII-mediated GKAP degradation. However, we did not observe a specific association of TRMI3 with the pSer54 peptide or the GKAP S54D mutant by pull-down assays (data not shown), indicating that TRIM is unlikely involved in the CaMKII-dependent degradation of GKAP described here. CDK5 is another protein kinase involved in the GKAP degradation induced by soluble amyloid β 49 . However, this also likely represents an independent GKAP regulatory mechanism, as the CDK5 phosphorylation sites in GKAP are different from the CaMKIIα sites, and notably, CaMKII inhibitors did not prevent GKAP degradation by soluble amyloid β 49 .
Finally, recent studies on knockout mice lacking SAPAP-3, a GKAP family member highly expressed in the striatum, showed unexpected behavioral abnormalities similar to obsessive-compulsive disorder 50 . Our findings of the critical role of GKAP in synapse remodeling and homeostatic plasticity offer potentially new ways to think about the pathophysiology of this condition.
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Methods and any associated references are available in the online version of the paper.
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